Protein clues may forecast bladder cancer's return
NCT ID NCT07657299
First seen Jun 24, 2026
Summary
This completed study looked at whether three proteins (E-cadherin, β-catenin, and SOX4) can predict if non-muscle invasive bladder cancer will return or get worse. Researchers examined tissue samples from 30 patients who had bladder tumor removal surgery. The goal was to see if changes in these proteins could help doctors better understand a patient's risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of medicine, Ain Shams University
Cairo, Abbasia, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict which bladder cancers are likely to return or progress, leading to more personalized follow-up care.
What could go wrong
This is a small, retrospective study with only 30 participants, so results may not apply to all patients. It only looks at protein markers, not a treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.